George Washington University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, George Washington University sits in the top decile of US sponsors by registered trial count (#208 of 15,742 sponsors by registered trial count).
George Washington University: 133 sponsored US clinical trials, 24 recruiting.
George Washington University sponsors 133 registered US clinical trials on ClinicalTrials.gov, 24 of them currently recruiting, and 88 completed. 11 of these trials are in Phase 3-4 (later-stage) and 18 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Postpartum Hemorrhage, with 2 trials.
Top-decile sponsor footprint
George Washington University ranks in the top decile of sponsors by registered trial count (#208 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
88 of 102 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (86.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
133 total, page 1 of 3
Support Your Heart, Phase 1
NCT07623733
A Basket Clinical Study to Assess Glycerol Tributyrate in Patients With Mitochondrial Encephalopathy, Lactic Acidosis, Stroke-like Episodes (MELAS) or Leber's Hereditary Optic Neuropathy-Plus (LHON-Plus)
NCT06792500
NSS Grocery Store Brazil
NCT07249008
Hemoglobin Testing in Pregnant Patients
NCT05977686
Effectiveness Study of a Lifestyle Intervention Versus Metformin in Mothers With Recent Gestational Diabetes
NCT06948825
Single Shot Exparel vs Catheters in Lower Extremity Trauma
NCT07221019
Controlled Human Infection Study of Orally Administered Trichuris Trichiura Eggs in Naïve Adults
NCT05706116
Changing Youth Narratives on Firearm Violence ("Run It Up") Intervention
NCT06940362
Erector Spinae Versus Intercostal Nerve Blocks With Liposomal Bupivacaine for Analgesia in Thoracic Surgery
NCT06810375
Implementing a Scalable Smoke-free Home Intervention in Armenia and Georgia
NCT06166433
How a Single Workout Affects Gut Bugs in Women With Different Fitness Levels and Body Types
NCT06691100
DISCOVERY of Risk Factors for Type 2 Diabetes in Youth
NCT06525259
Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT)
NCT06806930
Effects of a Non-nutritive Sweetener Reduction Intervention in Pregnancy and Lactation on Maternal and Infant Outcomes
NCT06548828
Impact of Early ADL Education on Outcomes Post DRF ORIF
NCT06251206
Prevent Cardiac Surgery Associated AKI Trial
NCT06620523
HAVEN-Connect Youth Suicide Prevention
NCT07401940
Impact of Early ADL Participation on Outcomes Post DRF
NCT05650996
Texts for Diabetes Control Among Homeless Persons
NCT05616026
REstoring Mental Health Through COmmUnity-based Psychological Services in New York City
NCT04913766
Erector Spinae Block for Thoracic Surgery
NCT05521789
Diagnostic Yield of Intranodal Forceps Biopsies in Mediastinal Adenopathy
NCT05374447
Trigger Point Injections in Anterior Cervical Surgery
NCT04640896
The DC Cohort Longitudinal HIV Status Neutral Study
NCT01206920
CARE (Chemotherapy Alopecia REduction)
NCT07201389
Diet, Hepcidin, and Chemotherapy RDI
NCT06483997
Plant-based Diet for Kidney Transplant Recipients
NCT06186843
Parent-focused Intervention to Reduce HIV Risk in Gay and Bisexual Adolescents
NCT05852600
Decision Support Tool to Integrate PrEP Into Emergency Departments
NCT07279129
ChatGPT-Supported Text Messaging Program for Smoking Cessation
NCT07079306
Colorectal Cancer Screening in the Homeless
NCT07220018
Developing a Tailored Psychosocial Education Intervention for Chronic Pain Management for Asian Americans
NCT06725329
Protective Effect of Exercise on Acute High-fat Overfeeding
NCT07633704
Effect of Caloric Content and Timing of Meal on Postprandial Substrate Oxidation and Pulse Wave Analysis
NCT07122765
Metabolic Adaptations to High-fat Diet
NCT06537401
Preoperative iLux on Cataract Surgery Derived Dry Eye Disease Due to Meibomian Gland Dysfunction
NCT06483750
mHealth for Young Adult Cancer Survivors
NCT05905250
Brain Health & the Microbiome
NCT06039267
Inner Speech and Naming Treatment for Individuals with Aphasia
NCT05980897
Effect of Sunflower Lecithin Supplementation on Meibomian Gland Function in Adults With Dry Eye Disease
NCT06058559
PositiveLinks: mHealth for DC Cohort
NCT04998019
Educational Video's Impact on Knowledge Regarding Cervical Cancer Screening
NCT05756192
Uncontrolled Hypertension Among the Homeless
NCT05187013
Racial Discrimination, Pain, and the Buffering Influences of Acknowledgment
NCT06113926
Creating A Cardiorenal Multidisciplinary Team for Management HF and CKD Patients
NCT05531214
Dual-task Training in Older Adults
NCT05296551
Intergenerational Transmission of Low-calorie Sweeteners Via Breast Milk
NCT05379270
Discussing COVID-19 Vaccines in Private Facebook Groups
NCT05422898
Honoring Individual Goals and Hopes: Implementing Advance Care Planning for Persons With Kidney Disease on Dialysis
NCT05324878
Efficacy Trial of Life Simulation Game to Routinize Adolescent HIV Testing
NCT04917575
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 11 |
| Phase 2 | 7 |
| Phase 3 | 1 |
| Phase 4 | 10 |
What is open in the George Washington University pipeline
24 recruiting of 133 indexed (18% open); 88 completed (66%).
Phase mix: 11 late (III/IV) vs 18 early (I/II) (early-phase heavy).
Top condition: Postpartum Hemorrhage (2 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
George Washington University: open-pipeline peers nationwide
Peers matched on 133 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
George Washington University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 133 trials (± recruiting share)
- Millennium Pharmaceuticals · 135 trials · 0% recruiting
- National Institute on Aging (NIA) · 131 trials · 9% recruiting
- The Miriam Hospital · 136 trials · 11% recruiting
- Rhode Island Hospital · 130 trials · 20% recruiting
Sponsors near 18% open enrollment (± trial volume)
- Hospital for Special Surgery, New York · 18% recruiting · 194 trials
- University of California, Berkeley · 18% recruiting · 72 trials
- West Virginia University · 18% recruiting · 122 trials
- Children's Hospital of Philadelphia · 18% recruiting · 431 trials
Related
What to do with this George Washington University page
133 registered trials is a research-attention snapshot, not an endorsement of George Washington University or any single study.
- 24 of George Washington University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Postpartum Hemorrhage is the condition George Washington University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Postpartum Hemorrhage trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
George Washington University pipeline card: 133 registered trials from official public datasets.Report a data error.